Correlation Between Molecular Partners and Radcom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Radcom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Radcom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Radcom, you can compare the effects of market volatilities on Molecular Partners and Radcom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Radcom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Radcom.

Diversification Opportunities for Molecular Partners and Radcom

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Molecular and Radcom is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Radcom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Radcom and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Radcom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Radcom has no effect on the direction of Molecular Partners i.e., Molecular Partners and Radcom go up and down completely randomly.

Pair Corralation between Molecular Partners and Radcom

Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Radcom. But the stock apears to be less risky and, when comparing its historical volatility, Molecular Partners AG is 1.03 times less risky than Radcom. The stock trades about -0.03 of its potential returns per unit of risk. The Radcom is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,189  in Radcom on November 3, 2024 and sell it today you would earn a total of  94.00  from holding Radcom or generate 7.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Molecular Partners AG  vs.  Radcom

 Performance 
       Timeline  
Molecular Partners 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Radcom 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Radcom are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Radcom displayed solid returns over the last few months and may actually be approaching a breakup point.

Molecular Partners and Radcom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molecular Partners and Radcom

The main advantage of trading using opposite Molecular Partners and Radcom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Radcom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Radcom will offset losses from the drop in Radcom's long position.
The idea behind Molecular Partners AG and Radcom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope